Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for Thrombocytopenia in Chronic Liver Disease (ELEVATE)
NCT00678587Phase 3Terminated
- Sponsor
- GSK
- Start
- Jun 2008
- Primary completion
- Oct 2009
- Countries
- 13
01
Overview
A Phase 3 trial of eltrombopag in Thrombocytopenia, sponsored by GSK. Started Jun 2008; status: terminated.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00678587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678587.